Sign In
Free Newsletter
May 28, 2014
Advances outpace investors: Insiders say in-state bioindustry investment is lagging
Bharath Takulapalli is co-founder and CEO of INanoBio in Tempe. His company is completing a prototype for a fourth-generation genome sequencing machine that would make genome diagnostics faster, easier and much less expensive, so that more doctors and patients could benefit from earlier diagnosis of disease.
May 28, 2014
Biosensors and the need for early disease detection
The American Cancer Society predicts that in 2014, more than 1.6 million new cases of cancer will arise in the United States and more than half a million people will die from the disease, with 11,400 of those deaths occurring in Arizona. The treatment challenge remains in detecting the disease early enough to have a chance in successfully combating it.
